SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001845459-24-000012
Filing Date
2024-05-20
Accepted
2024-05-20 16:55:51
Documents
89
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q nkgn-20240331.htm   iXBRL 10-Q 1439413
2 EX-31.1 nkgenbiotechinc-exhibit311.htm EX-31.1 8361
3 EX-31.2 nkgenbiotechinc-exhibit312.htm EX-31.2 8397
4 EX-32.1 nkgenbiotechinc-exhibit321.htm EX-32.1 6507
  Complete submission text file 0001845459-24-000012.txt   9457548

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nkgn-20240331.xsd EX-101.SCH 82529
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nkgn-20240331_cal.xml EX-101.CAL 70679
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nkgn-20240331_def.xml EX-101.DEF 590342
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nkgn-20240331_lab.xml EX-101.LAB 757556
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nkgn-20240331_pre.xml EX-101.PRE 698756
93 EXTRACTED XBRL INSTANCE DOCUMENT nkgn-20240331_htm.xml XML 1119417
Mailing Address 3001 DAIMLER ST, SANTA ANA CA 92705
Business Address 3001 DAIMLER ST, SANTA ANA CA 92705 (949) 396-6830
NKGen Biotech, Inc. (Filer) CIK: 0001845459 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40427 | Film No.: 24965414
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)